New cases of thalidomide embryopathy in
β
Lavinia Schuler-Faccini; Rosa Castalia Franca Soares; Artur Custodio Moreira de
π
Article
π
2007
π
John Wiley and Sons
π
English
β 47 KB
## Abstract Thalidomide is the best known human teratogen. Although withdrawn from the market in 1961, thalidomide was remarketed after 1965 in several countries, for the treatment of erythema nodosum leprosum. Thalidomide has a potent immunomodulatory property and has now a number of approved and